ProMIS Neurosciences Inc. SEC filings PMN
ProMIS Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 29, 2026 | — |
| S-3 | Shelf registration | Mar 25, 2026 | — |
| S-3 | Shelf registration | Mar 18, 2026 | — |
| S-3 | Shelf registration | Sep 4, 2025 | — |
| S-8 | Employee stock plan registration | Aug 13, 2025 | — |
| S-3 | Shelf registration | Aug 13, 2025 | — |
| 424B5 | Prospectus supplement | Jul 22, 2025 | — |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2024 | — |
| 424B5 | Prospectus supplement | Apr 1, 2024 | — |
| 424B5 | Prospectus supplement | Jan 5, 2024 | — |
| S-3/A | Filing | Sep 27, 2023 | — |
| S-3/A | Filing | Sep 27, 2023 | — |
| S-3 | Shelf registration | Sep 22, 2023 | — |
| POS AM | Filing | Sep 22, 2023 | — |
| S-3 | Shelf registration | Sep 22, 2023 | — |
| 424B3 | Prospectus | Aug 22, 2023 | — |
| 424B3 | Prospectus | Aug 14, 2023 | — |
| 424B3 | Prospectus | Jul 14, 2023 | — |
| 424B3 | Prospectus | Jul 10, 2023 | — |
| 424B3 | Prospectus | Jun 30, 2023 | — |
| 424B3 | Prospectus | May 18, 2023 | — |
| 424B3 | Prospectus | May 8, 2023 | — |
| 424B3 | Prospectus | Apr 27, 2023 | — |
| 424B3 | Prospectus | Apr 10, 2023 | — |
| 424B3 | Prospectus | Apr 3, 2023 | — |
| POS AM | Filing | Mar 17, 2023 | — |
| 424B3 | Prospectus | Dec 6, 2022 | — |
| 424B3 | Prospectus | Nov 14, 2022 | — |
| S-1/A | Amended registration statement | Nov 8, 2022 | — |
| S-1/A | Amended registration statement | Nov 4, 2022 | — |
| S-1 | Registration statement | Nov 1, 2022 | — |
| S-8 | Employee stock plan registration | Sep 7, 2022 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto, Ontario, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1374339
- Former names
- AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.